KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $1.2 billion.

  • Bio-Rad Laboratories' Non-Current Debt rose 10.83% to $1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year increase of 10.83%. This contributed to the annual value of $1.2 billion for FY2025, which is 10.83% up from last year.
  • Bio-Rad Laboratories' Non-Current Debt amounted to $1.2 billion in Q4 2025, which was up 10.83% from $1.2 billion recorded in Q3 2025.
  • Bio-Rad Laboratories' 5-year Non-Current Debt high stood at $1.2 billion for Q4 2025, and its period low was $10.5 million during Q4 2021.
  • For the 5-year period, Bio-Rad Laboratories' Non-Current Debt averaged around $961.5 million, with its median value being $1.2 billion (2023).
  • Its Non-Current Debt has fluctuated over the past 5 years, first crashed by 1452.03% in 2021, then soared by 1129163.02% in 2022.
  • Over the past 5 years, Bio-Rad Laboratories' Non-Current Debt (Quarter) stood at $10.5 million in 2021, then soared by 11291.63% to $1.2 billion in 2022, then grew by 0.12% to $1.2 billion in 2023, then grew by 0.11% to $1.2 billion in 2024, then grew by 0.11% to $1.2 billion in 2025.
  • Its last three reported values are $1.2 billion in Q4 2025, $1.2 billion for Q3 2025, and $1.2 billion during Q2 2025.